FAKTOR OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Deutsche Boerse AG 01:20:30 02/07/2024 am IST | ||
| 23.49 EUR | +1.34% |
|
| Current month | +1.34% | ||
| 1 month | +25.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 23.49 | +1.34% |
| 28/24/28 | 23.18 | +0.22% |
| 27/24/27 | 23.13 | +0.87% |
| 26/24/26 | 22.93 | +0.09% |
| 25/24/25 | 22.91 | +2.09% |
Delayed Quote Deutsche Boerse AG
Last update July 02, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PD2LLY |
| ISIN | DE000PD2LLY7 |
| Date issued | 15/09/2021 |
| Strike | 905.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 23.54 € |
|---|---|
| Lowest since issue | 1.79 € |
| Spread | 0.02 € |
| Spread % | 0.08% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.97%
- Stock Market
- Certificates
- Certificat
